Clinical research studies are now evaluating an investigational influenza vaccine for adults 65 years of age and older. The studies are designed to assess how the vaccine may help protect generally healthy older adults during flu season. Participation lasts approximately 6-8 months and includes study-related care, health assessments, and regular monitoring by a clinical team. Eligible participants may include adults 65 and older who have not had a flu shot or flu infection within the past 6 months.
Influenza (the flu) can pose serious health risks for older adults, sometimes leading to complications that require medical care. Managing flu risk each season often means staying current on vaccinations and taking extra precautions. Researchers are now evaluating an investigational influenza vaccine to better understand its potential to help protect generally healthy adults 65 and older who have not had a flu shot or flu infection in the past 6 months. These clinical studies aim to gather more information on how this approach may work alongside current care strategies.
Your privacy is important to us. By completing the following pre-screener you agree to our Privacy Policy and Terms of Use, and agree that we may retain the personal information you provide and share it with personnel involved in the study, or otherwise as described in the Privacy Policy, and we or our affiliates may contact you by phone using automated technology or pre-recorded voicemail or other means including but not limited to text messages (standard messaging rates may apply) regarding research studies.